The deal was held up in court amid Daiichi Sankyo's long-running dispute with the Singh brothers over its purchase of Ranbaxy Laboratories more than a decade ago
Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles
The latest petition filed by NTK seeks another 2.7 million rupees for losses arising from the unit's defamation claim against Daiichi Sankyo and accrued interest on the damages claimed
The arbitral award is also under challenge by Singh brothers in Singapore Court of Appeals.